NCT00735267 · Interventional trial
A 52-Week Open-Label Safety Study of PD 0332334 in Subjects With Generalized Anxiety Disorder (GAD)
Overall registry status Terminated
Phase 3
Conditions Generalized Anxiety Disorder
Delaware Valley sites
- Pfizer Investigational Site · Media, PA · Delaware County
- Pfizer Investigational Site · Norristown, PA · Montgomery County
- Pfizer Investigational Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory